MORGAN STANLEY - MYOVANT SCIENCES LTD ownership

MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 91 filers reported holding MYOVANT SCIENCES LTD in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of MYOVANT SCIENCES LTD
ValueSharesWeighting
Q4 2022$12,430,178
+413.0%
461,060
+241.9%
0.00%
Q3 2022$2,423,000
-23.8%
134,872
-47.3%
0.00%
Q2 2022$3,180,000
-50.3%
255,799
-46.8%
0.00%
-100.0%
Q1 2022$6,402,000
+18.7%
480,676
+38.8%
0.00%0.0%
Q4 2021$5,393,000
+153.2%
346,402
+264.8%
0.00%
Q3 2021$2,130,000
-61.0%
94,958
-60.4%
0.00%
-100.0%
Q2 2021$5,465,000
+20.8%
240,056
+9.2%
0.00%0.0%
Q1 2021$4,524,000
-44.3%
219,844
-25.2%
0.00%0.0%
Q4 2020$8,120,000
+255.8%
294,008
+81.0%
0.00%
Q3 2020$2,282,000
+22.9%
162,425
+80.4%
0.00%
Q2 2020$1,857,000
-50.9%
90,054
-82.0%
0.00%
-100.0%
Q1 2020$3,781,000
+554.2%
500,851
+1243.4%
0.00%
Q4 2019$578,000
+89.5%
37,281
-36.4%
0.00%
Q3 2019$305,000
-54.7%
58,625
-21.1%
0.00%
Q2 2019$673,000
+691.8%
74,337
+1970.7%
0.00%
Q1 2019$85,000
+304.8%
3,590
+180.9%
0.00%
Q4 2018$21,000
-98.0%
1,278
-96.8%
0.00%
Q3 2018$1,067,000
+147.6%
40,154
+113.0%
0.00%
Q2 2018$431,000
+1206.1%
18,848
+1130.3%
0.00%
Q1 2018$33,000
+266.7%
1,532
+121.7%
0.00%
Q4 2017$9,000
-78.0%
691
-73.7%
0.00%
Q3 2017$41,000
+10.8%
2,629
-17.7%
0.00%
Q2 2017$37,000
-89.1%
3,195
-89.0%
0.00%
Q1 2017$340,000
-58.5%
28,980
-56.0%
0.00%
Q4 2016$820,00065,8600.00%
Other shareholders
MYOVANT SCIENCES LTD shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 85,000$1,132,0001.20%
Bellevue Group AG 5,859,039$78,042,0000.91%
APIS CAPITAL ADVISORS, LLC 40,000$533,0000.64%
Pier Capital, LLC 294,954$3,929,0000.50%
Resolute Capital Asset Partners LLC 50,000$666,0000.42%
Rhenman & Partners Asset Management AB 249,300$3,321,0000.33%
Hennion & Walsh Asset Management, Inc. 409,079$5,449,0000.29%
TORRAY INVESTMENT PARTNERS LLC 79,868$1,064,0000.17%
PLATINUM INVESTMENT MANAGEMENT LTD 195,211$2,600,0000.08%
DUALITY ADVISERS, LP 54,164$721,0000.08%
View complete list of MYOVANT SCIENCES LTD shareholders